azides has been researched along with zalcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, CK; Cretton, EM; Goudgaon, NM; Schinazi, RF; Sommadossi, JP; Xie, MY | 1 |
| Boudinot, FD; Chu, CK; Doshi, KJ; Eriksson, BF; McClure, HM; Oswald, B; Schinazi, RF; Sommadossi, JP | 1 |
| Asif, G; Coats, SJ; Detorio, M; Koontz, D; Mellors, JW; Meteer, JD; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Zhang, HW | 1 |
1 review(s) available for azides and zalcitabine
| Article | Year |
|---|---|
Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidine.
Topics: Animals; Antiviral Agents; Azides; Dideoxynucleosides; DNA-Directed DNA Polymerase; HIV-1; Humans; In Vitro Techniques; Kinetics; Macaca mulatta; Male; Mice; Rats; RNA-Directed DNA Polymerase; Zalcitabine | 1990 |
2 other study(ies) available for azides and zalcitabine
| Article | Year |
|---|---|
Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosides.
Topics: Animals; Antiviral Agents; Azides; Chromatography, High Pressure Liquid; Deoxyuridine; Dideoxynucleosides; Glucuronates; Hematopoietic Stem Cells; Microsomes, Liver; NADP; Oxidation-Reduction; Rats; Rats, Inbred Strains; Ribonucleosides; Uridine Diphosphate Glucuronic Acid; Zalcitabine; Zidovudine | 1992 |
The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Azides; Base Sequence; Dideoxyadenosine; Dideoxynucleosides; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Zalcitabine; Zidovudine | 2011 |